Tech Company M&A Transactions
Semprus BioSciences Acquisition
Semprus BioSciences, operating out of Cambridge, was acquired by Teleflex. Teleflex disclosed that the acquisition price was $30 million.
Transaction Overview
Company Name
Acquired By
Announced On
6/26/2012
Transaction Type
M&A
Amount
$30,000,000
M&A Terms
Teleflex paid $30 million upfront for Semprus, in additional to potential milestones, which were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
One Kendall Street Building 1400 1st Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Semprus BioSciences is a venture-backed biotechnology company developing functional surfaces to prevent medical device complications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Scott Rocklage
Chief Executive Officer
David Lucchino
Chief Technical Officer
Chris Loose
VP - Bus. Development
David McClellan
VP - Manufacturing
Douglas Weaver
VP - Product Management
Laurence Roth
Browse more venture capital transactions:
Prev: 6/26/2012: Alianza venture capital transaction
Next: 6/26/2012: U-Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs